FTO expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.646200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.619400E-01
Normal-vs-Stage2
6.445400E-01
Normal-vs-Stage3
2.977000E-01
Normal-vs-Stage4
1.040380E-01
Stage1-vs-Stage2
9.994400E-01
Stage1-vs-Stage3
3.393400E-01
Stage1-vs-Stage4
1.076080E-02
Stage2-vs-Stage3
3.577200E-01
Stage2-vs-Stage4
2.952300E-02
Stage3-vs-Stage4
1.806290E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.693000E-01
Normal-vs-AfricanAmerican
8.891800E-01
Normal-vs-Asian
2.551600E-01
Caucasian-vs-AfricanAmerican
5.238800E-01
Caucasian-vs-Asian
1.023620E-01
AfricanAmerican-vs-Asian
1.271400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.051800E-01
Normal-vs-Female
8.554000E-01
Male-vs-Female
4.177600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.383800E-01
Normal-vs-Age(41-60Yrs)
8.948600E-01
Normal-vs-Age(61-80Yrs)
6.695800E-01
Normal-vs-Age(81-100Yrs)
4.153800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.805800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.461000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.624400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.560200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.530500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.334600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.216200E-01
Normal-vs-Daily Drinker
2.820600E-01
Normal-vs-Weekly Drinker
6.198600E-01
Normal-vs-Occasional Drinker
9.149800E-01
Normal-vs-Social Drinker
7.623200E-01
Non Drinker-vs-Daily Drinker
8.132600E-01
Non Drinker-vs-Weekly Drinker
2.721400E-01
Non Drinker-vs-Occasional Drinker
4.704500E-02
Non Drinker-vs-Social Drinker
4.103600E-02
Daily Drinker-vs-Weekly Drinker
3.993000E-01
Daily Drinker-vs-Occasional Drinker
6.193700E-02
Daily Drinker-vs-Social Drinker
5.833600E-02
Weekly Drinker-vs-Occasional Drinker
3.556000E-01
Weekly Drinker-vs-Social Drinker
2.267600E-01
Occasional Drinker-vs-Social Drinker
6.995200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.503000E-01
Normal-vs-Grade 2
1.207830E-01
Normal-vs-Grade 3
1.519790E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.673000E-01
Grade 1-vs-Grade 3
7.461000E-01
Grade 1-vs-Grade 4
3.503000E-01
Grade 2-vs-Grade 3
9.335800E-01
Grade 2-vs-Grade 4
1.207830E-01
Grade 3-vs-Grade 4
1.519790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.131000E-01
Normal-vs-NonDiabetic
7.370000E-01
Diabetic-vs-NonDiabetic
4.144600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.494600E-01
Normal-vs-NoPancreatitis
7.265800E-01
Pancreatitis-vs-NoPancreatitis
8.102800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.384200E-01
Normal-vs-N1
6.840400E-01
N0-vs-N1
4.121800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.150400E-01
Normal-vs-TP53-NonMutant
8.956200E-01
TP53-Mutant-vs-TP53-NonMutant
5.461600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
